When you live inside a clinical trial for years, it becomes more than just a medical study. It becomes part of your life story. Five years is a long time.  It is filled with appointments, travel, tests, forms, and scans. It means having people checking on you constantly and knowing you are part of something much bigger than yourself. When it ended, I felt like a major chapter of my life was closing. A few things were happening at the same time: I was a patient, but I was also

This is the fourth post in our short series explaining the new global guidelines (ICH E6(R3)) through real patient experience, not complicated policy terms. Technology is everywhere in healthcare now, and clinical research is no different. You might hear terms like: Electronic consent (e-consent) Online portals Virtual visits Remote monitoring The Theory vs. the Reality In theory, all of this is meant to make research easier. Technology can be a real help when patients don’t

Everyone loves the miracle story. Hospice. No options left. Then a clinical trial. Then a second chance. For me, that second chance came through the early feasibility study of the EVOQUE transcatheter tricuspid valve replacement. I later continued follow-up as part of the TRISCEND II research studying this therapy for people living with severe tricuspid regurgitation, But what people don’t talk about very often is what happens after the miracle. When the swelling finally s

When people talk about clinical trials, they often talk about outcomes, data, and approvals. But what mattered most in my journey wasn’t just that a trial existed. It was how supported or unsupported I felt while living inside it. Behind every study are real people trying to survive long enough to reach the next option. And sometimes the hardest part isn’t the science. It’s the space in between. Here are some of the realities I lived through that rarely show up in trial repor

There’s a moment in healthcare that quietly shapes everything that comes after. I’ve lived it. It isn’t the test result, the gradient numbers, or even the final diagnosis. It’s the first contact. The first look. The first tone of voice. For me, that moment of safety didn't happen in a consultation room, it happened in a hallway during a 6-minute walk test. The Voice I Already Knew I remember my initial visit with the clinical trial doctors. It was during the height of COVID,

Cardiovascular disease is not rare. In the United States, nearly half of adults are living with some form of heart or blood vessel disease. It can affect anyone at any age, race, or background. But women face a different kind of risk. It is not just biological risk; it is a system risk. The medical system often fails to recognize these symptoms in women. Chest pain. Shortness of breath. Crushing fatigue. Dizziness. Swelling in your legs. Numbness that comes and goes. Too many

This is the third post in our five-part series explaining the new global guidelines (ICH E6(R3)) through real patient experience, not complicated policy terms.  Before someone joins a clinical study, they’re asked to sign an informed consent form. In theory, this form is supposed to help people understand: 🌀 What the study is about and what will be asked of them. 🌀 What the potential risks are. 🌀 That they have the absolute right to say "no." The Reality Gap That’s the

Structural heart disease is not always a one valve problem. In today’s world of rapid transcatheter innovation, new clinical trials for aortic, mitral, and tricuspid valve disease are changing lives. Patients who once had no options now have real hope through structural heart clinical trials and transcatheter therapies. Innovation is moving fast, and that is something to celebrate. But here is the question we need to start asking: what happens when a patient who joined one he

They say a picture is worth a thousand words. But when you live with heart valve disease, one medical note can explain years of symptoms. For a long time, I felt my body changing. I was tired all the time. My chest felt heavy. The swelling kept getting worse. But the focus stayed on my past surgeries and my pulmonary arteries. Meanwhile, something else was quietly progressing, severe tricuspid regurgitation. My echocardiograms showed moderate leakage in 2005. By 2014, it was

🫀 The 65+ Pulse Check You can’t protect what you don’t listen to. When was the last time someone listened to your heart? ❤️‍🩹 For many people over 65, shortness of breath, constant fatigue, or feeling “just a little slower” gets brushed off as normal aging. It’s not. These can be early warning signs of heart valve disease, a condition that is often treatable if caught early. At HeartBridge Collective (HBC), we believe no one should lose their independence or quality of life

This is the second post in our series explaining the new global guidelines (ICH E6(R3)) through real patient experience, not complicated policy terms. Clinical trials can feel overwhelming. So many visits. So many rules. So much paperwork. That’s where a newer idea comes in called Risk-Based Quality. Here’s what it really means: Not every part of a study carries the same level of risk. Some things matter a lot for patient safety and trust. Other things matter… less. Risk-base

Life can change fast . Sometimes it’s one symptom. One scan. One “we’re not sure yet.” And suddenly you’re on a long road you never asked to be on. My story isn’t just about heart disease. It started with an idiopathic rare disease  that most people including doctors have never even heard of. That rare disease set off a chain reaction that eventually led to something wild: a 52mm EVOQUE transcatheter tricuspid valve replacement —basically a new heart valve placed through a ca

February is Heart Month — and it holds more than one truth. Heart Month does important work. It raises awareness. It saves lives. It gets people talking. And there’s still a part of the conversation we don’t always make enough space for. Heart disease isn’t only about numbers, charts, or wearing red. It’s about real people living inside the system. ❤️‍🩹 It’s the woman whose symptoms were brushed off as stress or anxiety. ❤️‍🩹 The caregiver quietly holding everything togethe

This is the first post in a short series that explains ICH E6(R3) through real patient experience, not complicated policy terms. When people hear the words "clinical research," they often think of rules, paperwork, and checklists. But there’s a newer idea guiding research today called Quality by Design (QbD)—and it actually matters a lot to patients. Here’s the simple version: Quality by Design means researchers are supposed to think things through before a study starts, ra

Why good medical news can still feel scary when you’ve lived through heart failure Friday, I walked into my cardiology follow-up feeling pretty confident. I’ve been feeling really good. Like… good-good. More energy. More good days than hard ones. That stretch where you finally start to exhale and think, “Okay… maybe we’re steady.” So I expected a normal appointment. Maybe a “keep doing what you’re doing.” Maybe a small adjustment. But what I heard instead? I was not ready for

There’s a part of the recovery manual that’s missing. Hell, there is no recovery manual. After my heart event, my brain changed . And I’m not talking about ‘oops, I forgot where I put my keys.’ I’m talking about a system failure . I’m talking about the lights being on, but the wires being frayed. I’ll be in the middle of writing a blog… or sharing my lived experience… something I know in my bones… and then my mind goes blank. 📖 The word disappears. 📖 The thought disappears.

What the New Clinical Research Guidelines Mean for You Clinical research is changing. Here is what it actually feels like for you. When you’re a patient or a caregiver in a clinical trial, you don’t care about "regulatory updates" or "global compliance." You care about whether the study fits into your life. You care about whether you feel heard, safe, and respected. 👂❤️‍🩹 There is a new global guideline called ICH E6(R3) that is currently reshaping the future of research.

Tricuspid Valve Regurgitation, Explained in Plain Language I’m listening to a non-invasive cardiologist  explain tricuspid valve regurgitation (TR)  grades, and I hear this a lot: “Mild” and “trace” are clinically irrelevant.They don’t matter. I understand what that means medically .But here’s the truth — it still matters to patients. Let me explain why 👇 🩺 What Doctors Are Taught In medical training and guidelines: Trace or mild TR is very common Many healthy people have i

A reflection on love, responsibility, and learning to care for yourself while caring for someone else. I was caregiving long before I was able to consent to caregiving and simply because I loved my mom and I knew she needed help. I think one of the hardest parts of being a caregiver and someone who grew up in that role is you’re faced with understanding your own mortality, as well as others, very quickly. You quickly learn how complicated and unfair life is. You quickly learn

As this year comes to a close, I’ve been reflecting on the last 12 months of my personal life. A lot of it was heavy. A lot of it required honesty — even when I didn’t feel ready for it. If I’ve learned anything this year, it’s this: life doesn’t wait for us to feel ready. A Year That Didn’t Pause ⏳ This year, my husband Louis faced a cancer recurrence while I was dealing with my own cancer scare. There was no pause button.No moment where life slowed down so we could catch o